Chinanews client, Beijing, February 25th (Reporter Zhang Ni) "Have you been given the new crown vaccine?" After the Spring Festival, many people's greetings changed to this sentence.
Recently, some areas of the country have launched large-scale vaccination of the new crown vaccine.
How is the vaccination progress?
Is the vaccination capacity guaranteed?
When will the immune barrier be established?
These are the issues that ordinary people are most concerned about right now.
On February 2, people lined up at the gate of a vaccination spot in Chaoyang District, Beijing.
At present, various districts in Beijing are proceeding in an orderly manner with large-scale population COVID-19 vaccination.
Photo by China News Agency reporter Yang Kejia
How many people across the country have received the new crown vaccine?
Vaccination is the most powerful weapon to control the pandemic of infectious diseases.
On December 15, 2020, China officially launched the vaccination of key populations. For more than two months, the progress of new crown vaccine vaccination has been attracting attention.
Before the Spring Festival holiday, the news disclosed at the press conference of the Joint Prevention and Control Mechanism of the State Council showed that the new crown virus vaccination work for key populations was progressing smoothly. As of 24:00 on February 9, 40.52 million doses were reported nationwide.
From key populations to ordinary people, vaccination in various provinces is continuing to advance recently.
For example, starting from December 2020, Sichuan Province will promote the new crown vaccination work based on the key populations identified by the state.
As of February 21, 2021, Sichuan's new crown vaccine has accumulated more than 2.28 million doses. Among them, Chengdu, Mianyang, Neijiang, Leshan, Yibin, Dazhou and other places have completed the first dose of key populations.
In Beijing, starting from January this year, Beijing has carried out vaccination work for 9 key populations.
According to official data, as of February 21, the number of people in Beijing who had completed two shots of vaccination had reached 3.626 million.
Mass vaccination of vaccines will undoubtedly promote the rapid establishment of herd immunity.
Shao Yiming, a researcher at the Chinese Center for Disease Control and Prevention, recently emphasized in an interview with China News Agency that, based on the current situation, 80% of the population can be vaccinated to achieve a herd immune barrier.
On February 22, the staff of the Market Supervision Bureau of Xicheng District, Beijing posted a sign of "All you need to receive" for Tongheju (Yuetan Store).
Photo by China News Agency reporter Jia Tianyong
Are there enough vaccination points?
In order to ensure the advancement of vaccination work, the National Health Commission has organized and formulated a number of detailed technical plans earlier, including how to do preparations, how to set up vaccination points reasonably, how to organize and implement on-site, how to distribute and transport vaccines, and prevent abnormal reactions of vaccination Monitoring etc.
Regarding the setting of vaccination sites, the State Council’s joint prevention and control mechanism press conference held on January 9 this year revealed that there were 25,392 vaccination sites nationwide.
Recently, all localities are also actively expanding the number of vaccination sites.
For example, Beijing’s Chaoyang District announced on February 21 that at present, Chaoyang District has reserved the capacity to inoculate 100,000 people a day.
In the next step, the whole district plans to open more than 50 fixed vaccination sites, and add mobile sites as appropriate.
In Dongcheng District, Beijing, since February 8, Dongcheng District has tapped its potential and optimized the layout. The district has set up 17 new crown vaccination sites, increasing the number of vaccination stations to 81, and it is expected that more than 20,000 people can be vaccinated throughout the day.
According to information from the Health Commission of Tongzhou District, Beijing, 17 temporary vaccination sites in the district will accept scheduled vaccination from February 18th to May 12th. According to the principle of grid registration, it will be completed in two rounds to ensure completion in mid-May. Vaccination of mass population.
In terms of appointment vaccination, more convenient methods are also being opened in various places.
For example, Shanghai is continuing to make appointments for vaccinations against new crowns for students who go abroad for private work and learners, and appointments for vaccinations for new crowns vaccinated abroad for private use can be made through "subscriptions".
Data map: Medical staff inject vaccines for vaccinators.
Photo by China News Agency reporter Jiang Qiming
How effective is the vaccine?
How safe and effective is the new crown vaccine?
In response to this problem, Zhong Nanshan, an academician of the Chinese Academy of Engineering, said in a recent interview with the media that through tracking data, he learned that it has been almost 8 months since the first batch of vaccines in China, and the antibody of the vaccinators has remained at 90%. .
At present, the protection produced by Chinese vaccines can be maintained for at least half a year.
In addition, experts said that both Sinopharm and Kexing vaccines are inactivated vaccines and their safety is relatively high.
"The general adverse reaction of mild cases is 6 per 100,000, that is, symptoms such as fever and arm pain after vaccination, and the incidence of serious adverse reactions is one in a million. In contrast, the severe adverse reaction rate of influenza vaccine Three parts per million. More than 20 million people have been vaccinated with these two vaccines, and the safety of the vaccine has been tested." Zhong Nanshan said.
In addition, the official WeChat account of the Beijing Municipal Center for Disease Control and Prevention also released a popular science post a few days ago. Preliminary experiments have shown that more than 90% of the recipients will develop antibodies 28 days after the entire vaccination, and the protective effect is obvious.
A small number of people have redness, swelling, induration, and pain at the inoculation site after vaccination, and a very small number of people have symptoms such as fever, fatigue, nausea, headache, and muscle aches. They usually do not need treatment, and usually recover on their own in 1-2 days.
The Beijing Centers for Disease Control and Prevention also stated that safe and effective vaccines are the most powerful weapon for disease prevention. After vaccination, they can stimulate the body to produce immunity against the new coronavirus and block the new coronavirus infection.
Therefore, all people over the age of 18 and under 59 should receive the new crown vaccine without contraindications.
Data map: Medical staff prepare vaccines at the temporary vaccination site set up at the Chaoyang Planning Art Museum in Chaoyang District, Beijing.
Photo by China News Agency reporter Hou Yu
Is there a problem with the burden of vaccine costs?
The burden of vaccine costs is also the people's biggest concern.
Earlier, it was officially announced that the new crown vaccine is free of charge. Residents will not bear the cost, and the medical insurance fund and the finance will share it.
But building an immune barrier requires a relatively large proportion of the population to be vaccinated, so does the rolling balance of the medical insurance fund have enough capacity to protect it?
Regarding this issue, at the recent policy briefing held by the State Council Information Office, Shi Zihai, deputy director of the National Medical Insurance Administration, has made it clear that the current round of new coronavirus vaccine and vaccination cost policies have been clarified, and there are two main points: one is vaccine and The cost of vaccination is borne by the medical insurance fund, and the finance provides appropriate subsidies to the medical insurance fund. Residents are vaccinated for free.
The second is that the medical insurance fund is mainly borne by the balance of the past years, and does not affect the income and expenditure of the fund in the current period, that is, it does not affect the current medical treatment of the people.
Shi Zihai also said that at present, the National Medical Insurance Administration has worked with relevant departments to study and formulate a detailed operation plan for vaccine and vaccination cost guarantee after the vaccine is conditional on the market.
In the next step, we will guide all localities to organize and implement conscientiously to implement the good policies of the Party Central Committee and the State Council.
On January 29, people waiting for vaccination lined up for information registration at the temporary vaccination spot on Xueyuan Road Street, Haidian District, Beijing.
Recently, the second dose of the new crown vaccine for key populations in Haidian District, Beijing began to be carried out in an orderly manner.
Photo by China News Agency reporter Jiang Qiming
Is the vaccine production capacity guaranteed?
As a member of the global new crown vaccine research team, what is the current progress of China's new crown vaccine research and development and production capacity guarantee?
The State Food and Drug Administration has previously disclosed that 5 technical routes and a total of 16 vaccine varieties have been urgently approved for clinical trials, of which 6 vaccine varieties have started phase III clinical trials.
Up to now, two new coronavirus vaccines have been put on the market conditionally in China, namely, the new coronavirus inactivated vaccine of Sinopharm Sinopharm and the new coronavirus inactivated vaccine of Beijing Kexing Zhongwei.
On the 24th, there was another good news-Kang Sino issued an announcement stating that its conditional listing application for recombinant new coronavirus vaccine (type 5 adenovirus vector) was accepted by the State Food and Drug Administration.
From the perspective of production capacity, take the vaccines of Sinopharm and Kexing as examples. Previously, Sinopharm Zhongsheng Beijing Company announced that the production capacity of inactivated new coronavirus vaccines in 2021 could reach more than 1 billion doses. After the construction of the second-phase production line of Kexing Zhongwei Increase the annual production capacity to more than 600 million doses.
In the opinion of industry experts, the approval of more COVID-19 vaccines for clinical trials will undoubtedly allow China to have more COVID-19 vaccine reserves and be able to calmly respond to sudden outbreaks that may occur in the future.
(Finish)